No Evidence For Large-scale Germline Genomic Aberrations in Hereditary Bladder Cancer Patients with High-Resolution Array-Based Comparative Genomic Hybridization | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

No Evidence For Large-scale Germline Genomic Aberrations in Hereditary Bladder Cancer Patients with High-Resolution Array-Based Comparative Genomic Hybridization

Cancer Epidemiol Biomarkers Prev (2006) 15 (1): 180–183.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Are There Monogenic Hereditary Forms of Bladder Cancer or Only Genetic Susceptibilities?

Tarek Souaid
Joya-Rita Hindy
Ernest Diab
Hampig Raphael Kourie

Pharmacogenomics (2021) 22 (10): 619.

Familial and genetic risk of transitional cell carcinoma of the urinary tract

Christine M. Mueller
Neil Caporaso
Mark H. Greene

Urologic Oncology: Seminars and Original Investigations (2008) 26 (5): 451.

Hereditary bladder cancer

Lambertus A. L. M. Kiemeney

Scandinavian Journal of Urology and Nephrology (2008) 42 (sup218): 110.

Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk?

Cristiane Murta-Nascimento
Debra T. Silverman
Manolis Kogevinas
Montserrat García-Closas
Nathaniel Rothman
Adonina Tardón
Reina García-Closas
Consol Serra
Alfredo Carrato
Cristina Villanueva
Mustafa Dosemeci
Francisco X. Real
Núria Malats

Cancer Epidemiology, Biomarkers & Prevention (2007) 16 (8): 1595.

Advances in the Management of Superficial Bladder Cancer

Michael A. O’Donnell

Seminars in Oncology (2007) 34 (2): 85.